Home
About SiliconSnark
SiliconSnark Creations

Sign in Subscribe

Rare Disease

SiliconSnark robot rolls a glowing drug-application binder outside a Waltham biotech campus.

Boston Tech

Cogent Filed Its Third Bezuclastinib NDA, and Waltham Looks Weirdly Inevitable

Waltham-based Cogent filed an NDA for bezuclastinib in advanced systemic mastocytosis, turning a rare-disease bet into a serious 2026 launch race.

SiliconSnark robot outside a Cambridge biotech building with floating red blood cells and clinical charts.

Boston Tech

Agios Posted New Sickle Cell Data, and Cambridge Gets a Rare Clean Win

Agios unveiled detailed Phase 3 sickle cell data on June 13, 2026, giving Cambridge biotech a real win in a field where progress is hard to earn.

SiliconSnark

The internet’s snarkiest site for celebrating tech innovation, and calling out the nonsense.

SiliconSnark: Tech With a Wink

The internet’s snarkiest site for celebrating tech innovation, and calling out the nonsense.

Terms of Service
Privacy Policy
Contact

Powered by Ghost